Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13471 | 771 | 53.0 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
808 | 11353 | WISKOTT ALDRICH SYNDROME//GELSOLIN//COFILIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PODOSOMES | Author keyword | 88 | 70% | 9% | 73 |
2 | INVADOPODIA | Author keyword | 80 | 58% | 12% | 91 |
3 | CORTACTIN | Author keyword | 70 | 48% | 14% | 107 |
4 | PODOSOME | Author keyword | 42 | 49% | 8% | 62 |
5 | AFAP 110 | Author keyword | 21 | 90% | 1% | 9 |
6 | PROT FUNCT DISCOVERY PROGRAM | Address | 12 | 86% | 1% | 6 |
7 | TKS5 | Author keyword | 10 | 73% | 1% | 8 |
8 | TUMOR CELL INVAS | Address | 8 | 60% | 1% | 9 |
9 | XB130 | Author keyword | 8 | 100% | 1% | 5 |
10 | INVADOSOME | Author keyword | 7 | 67% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PODOSOMES | 88 | 70% | 9% | 73 | Search PODOSOMES | Search PODOSOMES |
2 | INVADOPODIA | 80 | 58% | 12% | 91 | Search INVADOPODIA | Search INVADOPODIA |
3 | CORTACTIN | 70 | 48% | 14% | 107 | Search CORTACTIN | Search CORTACTIN |
4 | PODOSOME | 42 | 49% | 8% | 62 | Search PODOSOME | Search PODOSOME |
5 | AFAP 110 | 21 | 90% | 1% | 9 | Search AFAP+110 | Search AFAP+110 |
6 | TKS5 | 10 | 73% | 1% | 8 | Search TKS5 | Search TKS5 |
7 | XB130 | 8 | 100% | 1% | 5 | Search XB130 | Search XB130 |
8 | INVADOSOME | 7 | 67% | 1% | 6 | Search INVADOSOME | Search INVADOSOME |
9 | INVADOPODIUM | 6 | 71% | 1% | 5 | Search INVADOPODIUM | Search INVADOPODIUM |
10 | HS1 | 6 | 45% | 1% | 10 | Search HS1 | Search HS1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PODOSOME FORMATION | 77 | 65% | 9% | 73 |
2 | EXTRACELLULAR MATRIX DEGRADATION | 57 | 38% | 16% | 121 |
3 | INVADOPODIA | 35 | 37% | 10% | 75 |
4 | EMS1 GENE | 31 | 82% | 2% | 18 |
5 | CORTACTIN | 23 | 25% | 10% | 80 |
6 | PODOSOMES | 23 | 36% | 7% | 53 |
7 | INVADOPODIA FORMATION | 22 | 55% | 4% | 28 |
8 | 3 DIMENSIONAL MIGRATION | 21 | 78% | 2% | 14 |
9 | FILAMENT NETWORK FORMATION | 17 | 43% | 4% | 30 |
10 | AFAP 110 | 17 | 79% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tools of the trade: podosomes as multipurpose organelles of monocytic cells | 2015 | 2 | 112 | 64% |
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function | 2011 | 213 | 139 | 49% |
Degrading Devices: Invadosomes in Proteolytic Cell Invasion | 2011 | 100 | 151 | 60% |
The matrix corroded: podosomes and invadopodia in extracellular matrix degradation | 2007 | 287 | 86 | 57% |
Invading one step at a time: the role of invadopodia in tumor metastasis | 2014 | 11 | 119 | 33% |
Invadopodia: The leading force | 2012 | 19 | 51 | 73% |
Pathological roles of invadopodia in cancer invasion and metastasis | 2012 | 27 | 93 | 56% |
Invadopodia: specialized cell structures for cancer invasion | 2006 | 181 | 64 | 48% |
Cortactin in tumor invasiveness | 2008 | 100 | 97 | 62% |
Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix | 2009 | 92 | 113 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROT FUNCT DISCOVERY PROGRAM | 12 | 86% | 0.8% | 6 |
2 | TUMOR CELL INVAS | 8 | 60% | 1.2% | 9 |
3 | CANC IMMUNOL CELL BIOL | 4 | 75% | 0.4% | 3 |
4 | UNIT ACTIN CYTOSKELETON REGULAT | 3 | 57% | 0.5% | 4 |
5 | NEUROGENET PROJECT | 3 | 100% | 0.4% | 3 |
6 | PROGRAM CANC CELL BIOL | 3 | 32% | 1.0% | 8 |
7 | CRUK BEATSON CANC | 2 | 67% | 0.3% | 2 |
8 | TUMOUR CELL INVAS | 2 | 50% | 0.4% | 3 |
9 | CNRS ERL5284 | 1 | 100% | 0.3% | 2 |
10 | WAKE FO T COMPREHENS CANC | 1 | 50% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000205325 | WISKOTT ALDRICH SYNDROME//X LINKED THROMBOCYTOPENIA//WISKOTT ALDRICH SYNDROME PROTEIN |
2 | 0.0000145648 | FASCIN//FASCIN 1//FASCIN1 |
3 | 0.0000110222 | EPS8//MTSS1//I BAR |
4 | 0.0000104715 | DYNAMIN//F BAR DOMAIN//AMPHIPHYSIN |
5 | 0.0000099342 | KBG SYNDROME//AARSKOG SCOTT SYNDROME//FACIOGENITAL DYSPLASIA |
6 | 0.0000084707 | FORMIN//FHOD1//CELL STRUCT SIGNAL INTEGRAT |
7 | 0.0000076039 | C FES//FER KINASE//FPS FES |
8 | 0.0000073162 | SWAP 70//SWITCH ASSOCIATED PROTEIN 70//DEF6 |
9 | 0.0000072760 | COFILIN//LIM KINASE//ADF COFILIN |
10 | 0.0000066765 | LCK INHIBITOR//SRC INHIBITORS//SRC |